| 注册
首页|期刊导航|原子与分子物理学报|Asp25质子化有利于HIV-1蛋白酶与抑制剂GRLO2O31结合

Asp25质子化有利于HIV-1蛋白酶与抑制剂GRLO2O31结合

伊长虹 陈建中 朱通 张庆刚

原子与分子物理学报2011,Vol.28Issue(1):11-16,6.
原子与分子物理学报2011,Vol.28Issue(1):11-16,6.DOI:10.3969/j.issn.1000-0364.2011.01.003

Asp25质子化有利于HIV-1蛋白酶与抑制剂GRLO2O31结合

Protonation of Asp25 of HIV-1 protease stabilizes its binding to the inhibitor GRL02031

伊长虹 1陈建中 2朱通 2张庆刚3

作者信息

  • 1. 山东师范大学物理与电子科学学院,济南,250014
  • 2. 山东交通学院数理系,济南,250023
  • 3. 中国科学院大连化物所分子模拟与设计实验室,大连,116023
  • 折叠

摘要

Abstract

GRL02031 is an inhibitor of the aspartate protease of HIV-1 and a potential therapeutic agent for AIDS. Determining the protonation state of Asp25/Asp25' in the protease-GRL02031complex (PR-031) is critical for understanding the binding mechanisms between the enzyme and the inhibitor and predicting the effects of mutations on drug sensitivity. Five-nanosecond molecular simulation was performed to analyze the effects of the four most possible protonation states of the aspartate residue on the dynamics of PR-031 binding. Relative binding free energies were calculated using the molecular mechanics/Possion-Boltzman surface area (MM-PBSA) method. The results showed that the OD2 protonation state of Asp25 in chain A is most favorable for the binding is therefore the most probable state. Moreover, analysis of hydrogen bonding on the water molecule that mediates PR-031 binding showed that the water molecule was the most stable under this protonation state. The study provides theoretical guidance for designing high affinity inhibitors and understanding mutation-induced drug resistance.

关键词

HIV-1蛋白酶/分子动力学/MM-PBSA方法/结合自由能/质子化

分类

生物科学

引用本文复制引用

伊长虹,陈建中,朱通,张庆刚..Asp25质子化有利于HIV-1蛋白酶与抑制剂GRLO2O31结合[J].原子与分子物理学报,2011,28(1):11-16,6.

基金项目

国家自然科学基金(10874104) (10874104)

山东省自然科学基金(Z2007A05) (Z2007A05)

原子与分子物理学报

OA北大核心CSCDCSTPCD

1000-0364

访问量0
|
下载量0
段落导航相关论文